Comparison of a Web-based Advance Directive to a Standard Advance Directive
NCT03676426 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2020-05-07
Summary
This study will compare a web-based advance directive to a standard advance directive.
Conditions
- GI Cancer
- Thoracic Cancer
Interventions
- OTHER
-
Web platform for advance care planning/advance directive
Ourcarewishes (OCW) is a web-based platform to document advance care planning based at Penn. OCW contains more detailed content on preferences and values than a standard advance directive and allows electronic sharing with loved ones and transmission to the Penn EHR.
- OTHER
-
Standard advance directive
Patients receive a paper copy of an advance directive used by social workers at Penn Medicine and are encouraged to complete on their own.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-15
- Primary Completion
- 2019-10-20
- Completion
- 2020-02-20
Countries
- United States
Study Locations
More Related Trials
-
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
NCT03198286 ·Status: COMPLETED ·Phase: NA
-
Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer
NCT01049425 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility
NCT00617370 ·Status: COMPLETED ·Phase: NA
-
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
NCT03939481 ·Status: ACTIVE_NOT_RECRUITING
-
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
NCT04703244 ·Status: RECRUITING
-
Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
NCT00270894 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Neoadjuvant Chemotherapy of Breast Cancer
NCT00830544 ·Status: UNKNOWN ·Phase: PHASE2
-
AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer
NCT00076024 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy in Treating Women With Breast Cancer
NCT00003519 ·Status: COMPLETED ·Phase: PHASE3
-
High Dose Chemotherapy and Autologous Transplant for Breast Cancer
NCT00186641 ·Status: UNKNOWN ·Phase: PHASE2
-
Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients
NCT02160366 ·Status: UNKNOWN
-
Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer
NCT01815242 ·Status: COMPLETED ·Phase: PHASE2
-
TAC Versus TC for Adjuvant Breast Cancer
NCT00493870 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer
NCT02613026 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer
NCT03705429 ·Status: COMPLETED ·Phase: PHASE3
-
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
NCT07216105 ·Status: RECRUITING ·Phase: PHASE1
-
Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors
NCT00851110 ·Status: TERMINATED ·Phase: PHASE2
-
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
NCT00436709 ·Status: UNKNOWN ·Phase: NA
-
Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer
NCT04809844 ·Status: UNKNOWN
-
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
NCT04001829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer
NCT00140075 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility
NCT00591851 ·Status: COMPLETED ·Phase: PHASE2
-
Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm
NCT00776724 ·Status: COMPLETED ·Phase: PHASE3
-
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
NCT00070564 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
NCT00002662 ·Status: COMPLETED ·Phase: PHASE3